PACKAGE 1

This tender, identified as 'PAKIET 1' (Package 1) and sourced from Poland via TED, concerns the supply of the pharmaceutical product Abemaciclibum. Abemaciclib is a medication used primarily in the treatment of certain types of breast cancer. The title 'PAKIET 1' indicates that this is one specific lot within a potentially larger pharmaceutical procurement. The contracting authority is seeking to secure a supply of this vital medication. Typical requirements for pharmaceutical tenders include strict adherence to regulatory standards set by health authorities (e.g., EMA in Europe), ensuring product authenticity, quality, and efficacy. Specifications will detail the exact pharmaceutical form (e.g., tablets, capsules), dosage strengths, packaging (e.g., blister packs, bottles), quantities, and expiry date management. Bidders, typically pharmaceutical manufacturers or authorized distributors, must provide proof of marketing authorization, demonstrate robust supply chain integrity, and meet stringent quality control measures. The tender documentation will outline the specific requirements, delivery schedules, storage conditions, and evaluation criteria, which heavily focus on product quality, regulatory compliance, and supply reliability. This procurement is critical for patient treatment and healthcare provision.